Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
Clinical trial NCT03548415 · COMPLETED
Trial details
- NCT number
- NCT03548415
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-13
- Primary completion
- 2021-02-18
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.